Minze NV

Minze NV specialises in urinary and continence care devices. Their portfolio includes portable and hospital-grade urinals like the Minze Potty and Minze Hospicup, tools for urodynamic assessment such as the Minze Uroflow and Minze Peehat, incontinence management aids like the Minze Shield, and patient monitoring systems including the Minze Diary and Minze Platform. These devices are designed to support bladder and continence management in various settings.

Minze NV is headquartered in Belgium. The company’s location in Belgium aligns with its focus on developing and distributing medical devices within the European market, where regulatory frameworks like the EU Medical Device Regulations apply.

Minze NV’s devices are listed in the EUDAMED database, which is the European Union’s central registry for medical devices. This database is used to track and verify the registration of devices under the EU Medical Device Regulations, ensuring transparency and compliance within the European market.

Minze NV’s devices are classified under the EU Medical Device Regulations as either Class I or Class IIa. The classification depends on factors like the intended use, risk associated with the device, and its interaction with the body. For example, simple urinals like the Minze Potty are typically Class I, while devices like the Minze Uroflow (used for diagnostic purposes) may fall under Class IIa due to their role in assessing patient conditions.

The classification determines the regulatory requirements for each device, including design controls, clinical evaluations, and post-market surveillance. For instance, Class IIa devices like some urodynamic tools require more rigorous evidence of safety and performance compared to Class I devices, such as the Minze Shield. This ensures that higher-risk devices undergo stricter scrutiny to protect patient safety while maintaining accessibility for lower-risk products.